Monday, May 23, 2022

Element Biosciences Sets Chief Commercial Officer

San Diego-based Element Biosciences, which is developing a new, DNA sequencing platform, said it has named Mark Aitkenhead, PhD, as Chief Commercial Officer. Aitkenhead was most recently General Manager for Cellular Analysis Instrumentation and Global Commercial Leader for the Clinical Next Generation Sequencing (NGS) Division at Thermo Fisher Scientific, where he had been since 2003. Element is backed by Fidelity Management & Research Company, JS Capital, Foresite Capital and Venrock.